What does a TORCH test check for?

Generally, a TORCH screening refers to a panel of four tests for infectious agents that can affect pregnancy outcomes, including tests for cytomegalovirus antibodies, Toxoplasma gondii antibodies, rubella virus antibodies, and herpes simplex virus type II antibodies. Patients are advised to follow medical guidance for appropriate treatment. Specific details are as follows:

1. Cytomegalovirus Antibodies

Infection with cytomegalovirus during pregnancy may cause fetal damage and ultimately lead to intrauterine fetal death. If newborns are infected with cytomegalovirus, they may develop jaundice, hemolytic anemia, brain injury, or thrombocytopenic purpura. Patients can be treated under medical supervision with medications such as ganciclovir injection or foscarnet sodium.

2. Toxoplasma Gondii Antibodies

Infection with Toxoplasma gondii during pregnancy may result in miscarriage, preterm birth, stillbirth, or hydrocephalus in infants. Patients can be treated under medical supervision with medications such as acetylspiramycin tablets or azithromycin dispersible tablets.

3. Rubella Virus Antibodies

Infection with rubella virus during pregnancy may lead to congenital malformations, congenital heart disease, or neurodevelopmental disorders in newborns. Patients can be treated under medical supervision with antiviral oral solution or acyclovir tablets.

4. Herpes Simplex Virus Type II Antibodies

Infection with herpes simplex virus during pregnancy may trigger miscarriage, preterm delivery, fetal malformations, or stillbirth. Neonatal infection with herpes simplex virus carries a high mortality rate, and survivors often suffer long-term complications. Patients can be treated under medical supervision with medications such as famciclovir tablets or calamine lotion.

If patients experience any discomfort or symptoms, it is recommended to seek timely medical evaluation at a hospital to avoid delays in diagnosis and treatment.